Arrabidaea chica chloroform extract modulates estrogen and androgen receptors on luminal breast cancer cells
- PMID: 35057779
- PMCID: PMC8773405
- DOI: 10.1186/s12906-022-03506-3
Arrabidaea chica chloroform extract modulates estrogen and androgen receptors on luminal breast cancer cells
Abstract
Background: Breast Cancer (BC) is the most common cancer in women worldwide and, although 70% of patients are responsive to selective Estrogen Receptor (ER) modulators such as Tamoxifen (Tam), patients' survival is comprised by resistance to endocrine therapy. Brazilian flora, especially the Amazon biome, is one of the richest global sources of native species with potentially bioactive compounds. Arrabidaea chica is a plant native to the Amazon that has been used in the treatment of different diseases. However, its action on BC remains unclear.
Methods: Herein the biological effects of the chloroform extract of A. chica (CEAC) were evaluated on BC cells and in in vivo model. After confirmation of CEAC antioxidant capacity, cells were treated with CEAC and Tam, alone and with CEAC+Tam. The cell viability was evaluated by MTT and hormone receptor transcripts levels were assessed (ESR1, ESR2 and AR). Finally, anticarcinogenicity of CEAC was recorded in Drosophila melanogaster through Epithelial Tumor Test (ETT).
Results: The study confirmed the antioxidant activity of CEAC. CEAC was selective for MCF-7, downregulating ESR2 and AR transcripts and upregulating ESR2 expression. The modulatory effects of CEAC on ERs did not differ between cells treated with Tam and with CEAC+Tam. Interestingly, previous treatment with CEAC, followed by treatment with Tam promoted a significant decrease in cell viability. The extract also presented anticarcinogenic effect in in vivo assay.
Conclusion: The bioassays on breast tumor cells demonstrated the antiproliferative activity of the extract, which modulated the expression of hormone receptors and sensitized luminal tumor cells to Tam. These results suggest that CEAC could be a complementary treatment for BC.
Keywords: Breast Cancer; Carcinogenicity; Hormone Receptors; Hormonotherapy; Natural Products.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures






Similar articles
-
Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer.Mol Cancer. 2013 Feb 4;12:9. doi: 10.1186/1476-4598-12-9. Mol Cancer. 2013. PMID: 23379261 Free PMC article.
-
Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer.Mol Pharmacol. 2020 Oct;98(4):364-381. doi: 10.1124/molpharm.120.000054. Epub 2020 Aug 12. Mol Pharmacol. 2020. PMID: 32788222 Free PMC article.
-
Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.Anticancer Res. 2006 May-Jun;26(3A):1773-84. Anticancer Res. 2006. PMID: 16827106
-
Napabucasin Attenuates Resistance of Breast Cancer Cells to Tamoxifen by Reducing Stem Cell-Like Properties.Med Sci Monit. 2019 Nov 24;25:8905-8912. doi: 10.12659/MSM.918384. Med Sci Monit. 2019. PMID: 31760402 Free PMC article.
-
Identification of hub genes in AR-induced tamoxifen resistance in breast cancer based on weighted gene co-expression network analysis.Breast Cancer Res Treat. 2023 Jan;197(1):71-82. doi: 10.1007/s10549-022-06788-w. Epub 2022 Nov 5. Breast Cancer Res Treat. 2023. PMID: 36334189
References
-
- Coughlin SS, Ekwueme DU. Breast cancer as a global health concern. Cancer Epidemiol. 2009;33(5):315–318. - PubMed
-
- WHO: Breast cancer: prevention and control. In.; 2018.
-
- Organization WH. Diet, nutrition, and the prevention of chronic diseases: report of a joint WHO/FAO expert consultation, vol. 916: World Health Organization; 2003. http://apps.who.int/iris/bitstream/handle/10665/42665/WHO_TRS_916.pdf;js.... - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous